Abstract:Zheng Yang, Zhanli Shi, Kun Fang, Danhong Ren Department of Intensive Care Unit, Hangzhou Red Cross Hospital, Hangzhou, Zhejiang Province, 310003, People's Republic of China Correspondence: Danhong Ren, Department of Intensive Care Unit, Hangzhou Red Cross Hospital, Hangzhou, Zhejiang Province, 310003, People's Republic of China, Email Background: Rickettsia japonica infection is a rare disease, it is rare to report critical and severe case caused by this disease in Zhejiang Province, China. Patient Concerns: We report a patient who initially sought medical attention due to fever and developed coma and convulsions during treatment. The patient did not develop typical eschar and rash. Eventually, the patient needed to be treated in the intensive care unit due to acute respiratory failure. Diagnoses: The patient was diagnosed with Rickettsia japonica bloodstream infection by metagenomic next-generation sequencing (mNGS). Outcomes: Due to the critical illness, the patient was transferred to the intensive care unit, received doxycycline and other treatments, and rapidly recovered and discharged. Conclusion: The patient developed a critical illness after being infected with Rickettsia , when the medical history is unclear and clinical symptoms and signs are atypical, it is necessary to use mNGS examination for diagnosis. Keywords: rickettsia japonica, rickettsiosis, infection, metagenomic next-generation sequencing, critical illness Rickettsioses are infectious diseases caused by obligate intracellular gram-negative bacteria. They are classified into four groups: the spotted fever group (SFG), typhus group (TG), transitional group (TRG), and ancestral group (AG). 1 Japanese spotted fever (JSF; a SFG rickettsiosis), caused by Rickettsia japonica , first reported in Tokushima Prefecture, Japan, in 1984. 2,3 This bacterium is a vector borne pathogen that is transmitted to humans through tick bites. Rickettsia japonica may not be easily detected by nucleic acid detection, especially when anti-rickettsial antibodies appear. In addition, there are some differences between the clinical characteristics of the onset in different regions. Therefore, various factors may lead to misdiagnosis, delay in starting treatment, and even lead to poor prognosis. 4,5 Here, we report a case of atypical JSF diagnosed by metagenomic next-generation sequencing (mNGS) 6 examination with severe complications. On April 19, 2022, an 83-year-old woman walked in the mountains and forests. On day three, she developed a high fever (maximum temperature 39.2°C), accompanied by chills, chest tightness, shortness of breath, cough, and fatigue. She did not pay attention at that time, did not seek medical attention, and the above symptoms did not alleviate. On April 22, 2022, she visited the fever clinic of a local hospital. Laboratory studies had shown normal white blood cells and thrombocytopenia. Her level of hs-CRP was 83.1mg/L. Cardiac troponin I was negative. The attending doctor considered pulmonary infection, an empirical therapy of ceftazidime was administered intravenously. However, the patient complained that her temperature still fluctuated, and she developed cough symptoms and increased shortness of breath. On April 28, 2022, the patient had no choice but to go to the emergency department of our hospital. The chest CT of the patient was suggestive of interstitial pneumonia, a small right pleural effusion. Subsequently, she was admitted to the respiratory department of our hospital. After admission, the attending physician conducted a general physical examination of the patient, but no abnormality was found. Due to the lack of evidence of pathogenic bacteria, respiratory doctors gave the patient positive attention, but the condition did not improve. On April 30, 2022, the patient underwent oral tracheal intubation due to deterioration of consciousness and acute respiratory failure, and was transferred to the ICU for continued treatment after intubation. The patient had a brief convulsion during admission to the intensive care unit, that night, we received the results of the mNGS test indicating that the patient was infected with Rickettsia japonica , nevertheless, exanthemata and eschar were not found throughout the patient's body. We gave the patient doxycycline (100mg/day) orally. The next day, her fever and other symptoms started to decline and subsided without any complications, after evaluation, the empirical anti-infection treatment plan was gradually reduced. During ICU treatment, she was in septic shock causing multiorgan failure, she required intravenous catecholamine for shock state, artificial ventilation for respiratory failure, an -Abstract Truncated-

Administration of Corticosteroids for Prompt Suppression of Cytokine Storm in Severe Cases of Japanese Spotted Fever

[Intravenous Minocycline and Levofloxacin for Treatment of Two Cases of Japanese Spotted Fever]

Evaluating the Efficacy and Side Effects of Corticosteroid Therapy in Severely ill COVID-19 Patients

Prompt diagnosis and appropriate treatment of Japanese spotted fever: A report of three cases

Corticosteroids May Have Negative Effects on the Management of Patients with Severe Fever with Thrombocytopenia Syndrome: A Case-Control Study

Effective Therapy of Tocilizumab on Systemic Juvenile Idiopathic Arthritis Associated Refractory Macrophage Activation Syndrome.

Japanese spotted fever in an area endemic to SFTS virus: Case report and review of the literature

Rapid dexamethasone treatment inhibits LPS-induced cytokine storm in mice

Japanese spotted fever complicated by acute sensorineural hearing loss

Japanese spotted fever complicated with pleural effusion in Zhejiang province, China: a case report and literature review

Corticosteroid Administration is Associated with Improved Outcome of Patients Presenting High Inflammatory Cytokine Levels During Septic Shock

Atypical Rickettsia japonica Infection Involving Critical Illness Diagnosed by Metagenomic Next-Generation Sequencing: A Case Report

Efficacy and safety of corticosteroids for septic shock in immunocompromised patients: A cohort study from MIMIC

Analysis of Differences in Characteristics of High-Risk Endemic Areas for Contracting Japanese Spotted Fever, Tsutsugamushi Disease, and Severe Fever With Thrombocytopenia Syndrome

Corticosteroid Therapy in Critically Ill Patients with COVID-19: a Multicenter, Retrospective Study

Effect of tocilizumab plus corticosteroid on clinical outcome in patients hospitalized with severe fever with thrombocytopenia syndrome: A randomized clinical trial

Hypothermia, bradycardia, and hypotension during glucocorticoid or cyclosporine A therapy in a boy with Kikuchi-Fujimoto disease

Combination therapy of Tocilizumab and steroid for management of COVID-19 associated cytokine release syndrome: A single center experience from Pune, Western India

A case report of fatal Rickettsia japonica bloodstream infection in Zhejiang, China

Relationship between earlier introduction of tocilizumab and glucocorticoid-sparing effects on the acute phase of adult-onset Still's disease

Clinical efficacy of low-dose glucocorticoid therapy for critically ill patients with severe fever with thrombocytopenia syndrome: A retrospective cohort study